1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. China >
  6. Xellera Therapeutics

Xellera Therapeutics Overview

Life ScienceCompany

Where is Xellera Therapeutics headquartered?

Xellera Therapeutics is headquartered in Hong Kong, China.

What sector is Xellera Therapeutics in?

Xellera Therapeutics is a life science company.

Xellera Therapeutics Ltd.

Unit 611, 6/F, Tower 1 Harbour Centre, 1 Hok Cheung Street, Hung Hom,
Hong Kong,
China,
www.xelleratherapeutics.com

Xellera Therapeutics Ltd. is dedicated to developing cell- and gene-based therapies. XT’s mission is to bring advanced therapeutic options to patients in an era of precision medicine. XT is focused on building a Good Manufacturing Practice (GMP) facility for generating clinical-grade human stem cell lines, initially within the Southern Chinese population. The goal of these clinical-grade stem cell libraries will be to enable quicker identification of suitable donor material for cell-based therapies, minimizing the wait and avoiding complications commonly associated with transplantation, such as immune rejection or side effects caused by immunosuppression.


Company Summary

SECTOR

Life Science


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Xellera Therapeutics

Life Science Companies , China Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for China Companies

Largest China Companies , Acquisitive China Companies , Recently Acquired China Companies , Recently Sold China Companies , Private China Companies , Public China Companies , Acquired China Companies , PE Backed China Companies
Mergr

Solution for

Product

Company

Legal